Brazilian Journal of Anesthesiology
https://app.periodikos.com.br/journal/rba/article/doi/10.1016/j.bjane.2013.03.026
Brazilian Journal of Anesthesiology
Scientific Article

Comparative evaluation of propofol in nanoemulsion with solutol and soy lecithin for general anesthesia

Avaliação comparativa do propofol em nanoemulsão com solutol e com lecitina de soja para anestesia geral

José Carlos Rittes; Guilherme Cagno; Marcelo Vaz Perez; Ligia Andrade da Silva Telles Mathias

http://dx.doi.org/10.1016/j.bjane.2013.03.026 Braz J Anesthesiol, vol.66, n3, p.225-230, 2016
PDF English
PDF Português
Downloads: 0
Views: 977

Abstract

ABSTRACT INTRODUCTION: The vehicle for propofol in 1 and 2% solutions is soybean oil emulsion 10%, which may cause pain on injection, instability of the solution and bacterial contamination. Formulations have been proposed aiming to change the vehicle and reduce these adverse reactions. OBJECTIVES: To compare the incidence of pain caused by the injection of propofol, with a hypothesis of reduction associated with nanoemulsion and the occurrence of local and systemic adverse effects with both formulations. METHOD: After approval by the CEP, patients undergoing gynecological procedures were included in this prospective study: control (n = 25) and nanoemulsion (n = 25) groups. Heart rate, noninvasive blood pressure and peripheral oxygen saturation were monitored. Demographics and physical condition were analyzed; surgical time and total volume used of propofol; local or systemic adverse effects; changes in variables monitored. A value of p < 0.05 was considered significant. RESULTS: There was no difference between groups regarding demographic data, surgical times, total volume of propofol used, arm withdrawal, pain during injection and variables monitored. There was a statistically significant difference in pain intensity at the time of induction of anesthesia, with less pain intensity in the nanoemulsion group. CONCLUSIONS: Both lipid and nanoemulsion formulations of propofol elicited pain on intravenous injection; however, the nanoemulsion solution elicited a less intense pain. Lipid and nanoemulsion propofol formulations showed neither hemodynamic changes nor adverse effects of clinical relevance.

Keywords

Propofol/pharmacology, Propofol/pharmacokinetics, Emulsions, Nanostructures, General anesthesia

Resumo

RESUMO INTRODUÇÃO: O veículo do propofol em soluções a 1 e 2% é a emulsão de óleo de soja a 10%, que pode provocar dor à injeção, instabilidade da solução e contaminação bacteriana. Formulações foram propostas com o objetivo de alterar o veículo e reduzir essas reações adversas. OBJETIVOS: Comparar a incidência de dor à injeção do propofol com a hipótese de redução associada à nanoemulsão e a ocorrência de efeitos adversos locais e sistêmicos com as duas formulações. MÉTODO: Após aprovação pelo Conselho de Ética em Pesquisa, foram incluídos neste estudo prospectivo pacientes submetidas a procedimentos cirúrgicos ginecológicos: grupos controle (n = 25) e nanoemulsão (n = 25). Foram monitorados frequência cardíaca, pressão arterial não invasiva e saturação periférica de oxigênio. Foram analisados dados demográficos e estado físico; tempo cirúrgico e volume total usado de propofol; efeitos adversos locais ou sistêmicos; alterações nas variáveis de monitoramento. Considerou-se significativo valor de p < 0,05. RESULTADOS: Não houve diferença entre os grupos em relação a: dados demográficos, tempos cirúrgicos, volume total usado de propofol, retirada do braço, presença de dor durante a injeção e variáveis de monitoramento. Verificou-se diferença estatística significativa na intensidade da dor no momento da indução da anestesia, com menor intensidade no grupo nanoemulsão. CONCLUSÕES: Ambas as formulações de propofol, lipídica e em nanoemulsão, elicitaram dor à injeção venosa, porém a solução de nanoemulsão promoveu dor em menor intensidade. O propofol lipídico e o propofol em nanoemulsão não apresentaram alterações hemodinâmicas e efeitos adversos de relevância clínica.

Palavras-chave

Propofol/farmacologia, Propofol/farmacocinética, Emulsões, Nanoestruturas, Anestesia geral

References

Glen JB, Davies GE, Thomson DS. An animal model for the investigation of adverse responses to i v. anesthetic agents and their solvents. Br J Anaesth. 1979;51:819-27.

Baker MT, Naguib M. Propofol the challenges of formulation. Anesthesiology. 2005;103:860-76.

Thompson KA, Goodale DB. The recent development of propofol (Diprivan). Intensive Care Med. 2000;26:S400-4.

Date AA, Nagarsenker MS. Design and evaluation of microemul- sions for improved parenteral delivery of propofol. AAPS PharmSciTech. 2008;9:138-45.

Sneyd JR, Rigby-Jones AE. New drugs and technologies, intra- venous anaesthesia is on the move (again). Br J Anaesth. 2010;105:246-54.

Morey TE, Modell JH, Shekhawat D. Anesthetic prop- erties of a propofol microemulsion in dogs. Anesth Analg. 2006;103:882-7.

Sudo RT, Bonfá L, Trachez MM. Caracterização anestésica da nanoemulsão não lipídica de propofol. Rev Bras Anestesiol. 2010;60:475-83.

Rodrigues TA, Alexandrino RA, Kanczuk ME. Avaliação comparativa entre propofol com dois veículos diferentes em nanoemulsão com solutol e com lecitina de soja em pacientes submetidos a procedimentos endoscópicos. Rev Bras Anestesiol. 2012;62:324-33.

Dubey PK, Kumar A. Pain on injection of lipid-free propofol and propofol emulsion containing medium-chain triglyceride a comparative study. Anesth Analg. 2005;101:1060-2.

Larsen B, Beerhalter U, Biedler A. Less pain on injection by a new formulation of propofol A comparison with propofol LCT. Anaesthesist. 2001;50:842-5.

Larsen R, Beerhalter U, Erdkönig R. Injection pain from propofol-MCT-LCT in children A comparison with propofol- LCT. Anaesthesist. 2001;50:676-8.

Rau J, Roizen MF, Doenicke AW. Propofol in an emulsion of long- and medium-chain triglycerides the effect on pain. Anesth Analg. 2001;93:382-4.

Sun NC, Wong AY, Irwin MG. A comparison of pain on intravenous injection between two preparations of propofol. Anesth Analg. 2005;101:675-8.

Yamakage M, Iwasaki S, Satoh J. Changes in concentrations of free propofol by modification of the solution. Anesth Analg. 2005;101:385-8.

Sim JY, Lee SH, Park DY. Pain on injection with microemul- sion propofol. Br J Clin Pharmacol. 2009;67:316-25.

Pederneiras SG, Duarte DF, Teixeira Filho N. Uso do propo- fol em anestesias de curta duração estudo comparativo com o tiopental. Rev Bras Anestesiol. 1992;42:181-4.

Claeys MA, Gepts E, Camus F. Haemodynamic changes dur- ing anaesthesia induced and maintained with propofol. Br J Anaesth. 1983;60:3-9.

Grounds RM, Twigley AJ, Carli F. The haemodynamic effects of intravenous induction Comparison of the effects of thiopentone and propofol. Anaesthesia. 1985;40:735-40.

Hug CC, McLeskey CH, Nahrwold NL. Hemodynamic effects of propofol - data from 24,771 patients. Anesth Analg. 1993;76:S154.

El-Beheiry H, Kim J, Milne B. Prophylaxis against the sys- temic hypotension induced by propofol during rapid-sequence intubation. Can J Anaesth. 1995;42:875-8.

Sato M, Tanaka M, Umehara S. Baroreflex control of heart rate during and after propofol infusion in humans. Br J Anaesth. 2005;94:577-81.

Kranke P, Eberhart LH. Postoperative nausea and vomi- ting rational algorithms for prevention and treatment based on current evidence. Anasthesiol Intensivmed Notfallmed Schmerzther. 2009;44:286-94.

5dcd75770e88253c1abf58f7 rba Articles
Links & Downloads
2352-2291 (Electronic) 0104-0014 (Printed)
Braz J Anesthesiol ©2024 All rights reserved.

Braz J Anesthesiol

Share this page
Page Sections